TITLE

Ethics guidelines strengthened but reach remains limited

AUTHOR(S)
Eggertson, Laura
PUB. DATE
February 2009
SOURCE
CMAJ: Canadian Medical Association Journal;2/17/2009, Vol. 180 Issue 4, p379
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the updated draft of ethics guidelines governing human research which was issued by the granting councils in Canada. It notes that the draft includes the expanded sections on aboriginal and qualitative research, and the chapters on genetic and human-tissue research and clinical trials. While some researchers praise the changes on the guidelines, it states that others believe that the alterations do not adequately address the problems related to the transition of health research from research-based institutions into community settings. Canada's Tri-Council policy which articulates ethical principles concerning researches which involves humans is also discussed.
ACCESSION #
36422178

 

Related Articles

  • Understanding global transition assessments. Wyrwich, Kathleen W.; Tardino, Vicki M. // Quality of Life Research;Aug2006, Vol. 15 Issue 6, p995 

    Objective: Several methods currently used for determining meaningful or important change in health-related quality of life (HRQoL) measures are anchored by global transition items. It can be empirically demonstrated that patients' responses to these gold standards for change do not...

  • They're Dying to Get In. Bjerklie, David // Time;4/22/2002, Vol. 159 Issue 16, p56 

    Discusses the difficulty of being able to participate in clinical trials in medicine. Benefits of the trials, including substantial doctor-patient interaction; Idea that it is not just the terminally ill who benefit from the attention, but also medically neglected or poorly informed subjects...

  • CHAPTER 26: Design Principles and Their Application in Preventive Field Trials. Brown, C. Hendricks // Handbook of Drug Abuse Prevention: Theory, Science, & Practice;2003, p523 

    The article provides a framework for assessing the quality of a preventive field trial. Such a framework is useful for three purposes. First, research scientists can direct their attention to a limited number of essential elements in designing and implementing new preventive trials. Second,...

  • How to Find a Trial. Smith, Ian K. // Time International (South Pacific Edition);11/22/99, Issue 47, p76 

    Offers information on patient enrollment in clinical drug trials. Researchers' need for patients as well as patients' need for treatment; Reasons adults do not participate in clinical drug trials; Where to locate trials. INSETS: Ace-ing It;Inside Information;Minitel Mini-Stroke;Couch Potatoes...

  • Blinding in clinical trials and other studies. Day, Simon J; Altman, Douglas G // BMJ: British Medical Journal (International Edition);08/19/2000, Vol. 321 Issue 7259, p504 

    Discusses the relevance of allocation concealment, or blinding, in clinical trial practice. Importance of blinding in trials when response criteria is subjective; Difficulties involved in conducting double blind trials; Risk of bias associated with inadequate blinding; Use of blinding in other...

  • Clinical Trial watch.  // Urology Times;1/1/2006, Vol. 34 Issue 1, p25 

    The article presents a list of clinical trials related to urology that were conducted in the U.S. In one of the trials Paciltaxel, Carboplatin and Gemcltabine are used for the Treatment of patients with Advanced Transitional Cell Cancer of the Bladder. In another trial researchers are studying...

  • Retaining Subjects Is Harder Than Recruiting Them. Engfer, Doug // Applied Clinical Trials;Oct2004, Vol. 13 Issue 10, p70 

    The article discusses the difficulty of retention in contrast with recruitment of subjects in clinical trials in the U.S. Percentage of retention rates and dropout rates; Potential benefits of improving retention; Importance of communication and education between the researcher and the subject;...

  • My Life as a Guinea Pig. Reno, Jamie // Newsweek;8/6/2001, Vol. 138 Issue 6, p42 

    Focuses on the author, who participated in a clinical trial that helped preserve him from non-Hodgkin's lymphoma. His participation in a chemotherapy regimen called CHOP; His experiences in a clinical trial of a drug called Bexxar, which put him in remission; View that although clinical trials...

  • Personalized Medicine Development. Newman, Thomas J.; Freitag, Jeffrey J. // Applied Clinical Trials;Jul2011, Vol. 20 Issue 7, p30 

    The article discusses the role of the clinical research organization (CRO) that continues to develop as the popularity of personalized medicine grows in the U.S. It offers an overview of the services offered by CROs in assisting sponsors of personalized clinical trials. Also, it provides...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics